What is Lexicon Pharmaceuticals's G&A?

Lexicon Pharmaceuticals (LXRX) reported G&A of $12.02M in Q4 2022.

How has Lexicon Pharmaceuticals's G&A changed year-over-year?

Lexicon Pharmaceuticals's G&A increased by 48.7% year-over-year, from $8.09M to $12.02M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Lexicon Pharmaceuticals LXRX G&A

Discontinued — last reported Q4 '22

G&A at other companies

CytokineticsCYTK

$91.72M+47.1%

Eton Pharmaceuticals, Inc.ETON

$10.45M+13.9%

Mineralys Therapeutics, Inc.MLYS

$20.98M+219%

Aurinia PharmaceuticalsAUPH

$22.03M+8.3%

Viking TherapeuticsVKTX

$13.98M-0.7%

Segments

By segment

See full

Reportable Segment$6.44M-17.7%

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+273%

Enterprise value$976.73M+219%

P/S14.2×+5.7×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Lexicon Pharmaceuticals’s 10-K, filed March 3, 2023, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's G&A?: Lexicon Pharmaceuticals (LXRX) reported G&A of $12.02M in Q4 2022.
How has Lexicon Pharmaceuticals's G&A changed year-over-year?: Lexicon Pharmaceuticals's G&A increased by 48.7% year-over-year, from $8.09M to $12.02M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.